MARGONATO, ALBERTO
 Distribuzione geografica
Continente #
AS - Asia 5.228
NA - Nord America 2.998
EU - Europa 2.012
SA - Sud America 1.745
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 4
Totale 12.091
Nazione #
US - Stati Uniti d'America 2.867
SG - Singapore 2.279
BR - Brasile 1.463
CN - Cina 1.305
SE - Svezia 805
HK - Hong Kong 761
VN - Vietnam 460
RU - Federazione Russa 288
IT - Italia 247
DE - Germania 193
AR - Argentina 114
GB - Regno Unito 90
IN - India 83
IE - Irlanda 79
ID - Indonesia 62
MX - Messico 62
FI - Finlandia 61
AT - Austria 51
CA - Canada 49
BD - Bangladesh 48
EC - Ecuador 47
ZA - Sudafrica 43
FR - Francia 38
IQ - Iraq 38
CO - Colombia 33
NL - Olanda 33
PL - Polonia 33
ES - Italia 28
PY - Paraguay 27
TR - Turchia 27
JP - Giappone 23
UZ - Uzbekistan 23
UA - Ucraina 21
VE - Venezuela 17
PK - Pakistan 16
CL - Cile 14
UY - Uruguay 14
PE - Perù 13
IR - Iran 11
MA - Marocco 11
EG - Egitto 10
KR - Corea 10
LT - Lituania 10
IL - Israele 9
KE - Kenya 9
AE - Emirati Arabi Uniti 8
DO - Repubblica Dominicana 8
SA - Arabia Saudita 8
AZ - Azerbaigian 7
EU - Europa 7
JO - Giordania 7
RO - Romania 6
TN - Tunisia 6
AM - Armenia 5
OM - Oman 5
BG - Bulgaria 4
KZ - Kazakistan 4
NP - Nepal 4
AU - Australia 3
BE - Belgio 3
BO - Bolivia 3
ET - Etiopia 3
GA - Gabon 3
GR - Grecia 3
KW - Kuwait 3
PH - Filippine 3
PS - Palestinian Territory 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
BB - Barbados 2
BY - Bielorussia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
HN - Honduras 2
KG - Kirghizistan 2
MY - Malesia 2
TW - Taiwan 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CH - Svizzera 1
CI - Costa d'Avorio 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
KI - Kiribati 1
LB - Libano 1
MD - Moldavia 1
ML - Mali 1
MR - Mauritania 1
NG - Nigeria 1
Totale 12.081
Città #
Singapore 849
Dallas 777
Hong Kong 760
Shanghai 387
Ashburn 334
Hefei 317
Lawrence 299
Princeton 299
Beijing 155
Ho Chi Minh City 155
New York 141
Moscow 125
São Paulo 125
Milan 101
Hanoi 100
Dublin 79
Los Angeles 77
Rio de Janeiro 56
Nuremberg 55
Helsinki 49
Munich 43
Boardman 41
Curitiba 34
Warsaw 29
Johannesburg 28
Belo Horizonte 26
Haiphong 25
Brooklyn 24
Brasília 23
Porto Alegre 23
Santa Clara 23
Tashkent 22
Stockholm 21
Tokyo 21
Da Nang 20
Orem 20
Vienna 20
Campinas 19
Chicago 19
Guarulhos 19
London 19
Boston 18
Montreal 18
Baghdad 17
Chennai 17
Council Bluffs 17
Pune 17
Poplar 16
Quito 15
The Dalles 15
Washington 15
Goiânia 14
Jakarta 14
Denver 13
Dhaka 13
Guayaquil 13
Lima 13
Mexico City 13
Rome 13
Tianjin 13
Dronten 12
Guangzhou 12
Manaus 12
Santo André 12
Amsterdam 11
Asunción 11
Biên Hòa 11
Buenos Aires 11
Houston 11
Montevideo 11
Seattle 11
Shenzhen 11
Toronto 11
Ankara 10
Atlanta 10
Brescia 10
Campo Grande 10
Columbus 10
Frankfurt am Main 10
Medellín 10
Recife 10
Salvador 10
Thái Bình 10
Bogotá 9
Bắc Giang 9
Canoas 9
Caxias do Sul 9
Florianópolis 9
Fortaleza 9
Manchester 9
Rochester 9
São Bernardo do Campo 9
São Vicente 9
Turku 9
Aracaju 8
Delhi 8
Hanover 8
Mumbai 8
Nairobi 8
Piracicaba 8
Totale 6.437
Nome #
Prognostic impact of mitral regurgitation changes after TAVI 196
A comprehensive and easy-to-use ECG algorithm to predict the coronary occlusion site in ST-segment elevation myocardial infarction 158
470 MYOCARDIAL FIBROSIS IN ASYMPTOMATIC PATIENTS UNDERGOING SURGERY FOR MITRAL AND AORTIC VALVE REGURGITATION 151
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease 148
2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry 107
[New therapeutic options for the treatment of tricuspid regurgitation] 101
[Saphenous vein graft aneurysm: percutaneous exclusion using detachable coils] 97
Heart Valve Centre Approach to Severe Tricuspid Regurgitation: Real-World Data and Outcomes 86
[Cardiovascular involvement in Erdheim-Chester syndrome: clinical and therapeutic implications]. FT Coinvolgimento cardiovascolare nella sindrome di Erdheim-Chester: aspetti clinici e terapeutici. 84
Myocardial Late Contrast Enhancement CT in Troponin-Positive Acute Chest Pain Syndrome 83
[Heart and trauma: two representative cases of chest pain after high energy impact]. FT Dolore al petto e trauma toracico: casi clinici e revisione della letteratura. 81
"Ultrasound comet-tail images": A marker of pulmonary edema - A comparative study with wedge pressure and extravascular lung water 80
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 80
[Severe coronary artery disease and severely impaired renal function. Focused fluid expansion and ultra-low dose contrast medium administration] 78
Tricuspid Regurgitation in Left Ventricular Systolic Dysfunction: Marker or Target? 75
Clinical implication of multimodality imaging of aortic root intramural hematoma 74
[Changes in hemorheological parameters during physical exertion in coronary disease patients]. FT Alterazione di parametri emoreologici durante sforzo fisico in pazienti coronaropatici. 72
Baseline Characteristics and 3-Year Outcome of Nonvalvular Atrial Fibrillation Patients Treated with the Four Direct Oral Anticoagulants (DOACs) 71
Accuracy and reproducibility of aortic annular measurements obtained from echocardiographic 3D manual and semi-automated software analyses in patients referred for transcatheter aortic valve implantation: implication for prosthesis size selection 68
[Mitral regurgitation and hemodynamic changes in pregnancy]. FT Insufficienza mitralica e variazioni emodinamiche in gravidanza. 67
Grey zones on valvular heart disease: Interventional cardiology versus cardiac surgery. Expert opinion 67
Safety and efficacy of Direct Oral Anticoagulants (DOACs) in very elderly patients (≥ 85 years old) with non-valvular atrial fibrillation. The Experience of an Italian tertiary care center 67
A multicenter observational study on the management of hyperglycemia in patients with acute coronary syndrome 66
Amiodarone in ventricular arrhythmias: still a valuable resource? 66
The spectrum of covid-19-associated myocarditis: A patient-tailored multidisciplinary approach 65
[Multi-modality imaging: mycotic abscess of a pericardial patch]. FT Imaging multimodale: ascesso micotico su patch di pericardio 64
[Intravenous nitroglycerin infusion suppresses exercise-induced arrhythmia in patients with ischemic cardiopathy: indications for chronic treatment ]. FT L'infusione endovenosa di nitroglicerina sopprime le aritmie indotte da slorzo in pazienti con cardiopatia ischemica: indicazioni per il trattamento cronico. 63
[The coronary collaterals influence in the recovery phase after exercise-induced myocardial ischemia]. FT I collaterali influenzano la fase di recupero dopo ischemia miocardica indotta da esercizio. 62
Ambulatory ECG monitoring for the detection of myocardial ischaemia. Technical implications and applications for clinical trials 62
Advances in pharmacotherapy for cardiac amyloidosis 62
Left atrial appendage closure: a new strategy for cardioembolic events despite oral anticoagulation 62
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 59
[Right heart failure in a patient with unexplained tricuspid regurgitation and a rare congenital heart disease]. FT Scompenso cardiaco destro in un paziente con insufficienza tricuspidale di origine incerta e una rara cardiopatia congenita. 58
Long-term clinical outcomes of patients with rheumatoid arthritis and concomitant coronary artery disease 57
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 57
Atrial fibrillation in hypertrophic cardiomyopathy: pathophysiology, diagnosis and management 57
Pharmacotherapy for the treatment of obstructive hypertrophic cardiomyopathy 56
Effects of functional tricuspid regurgitation on renal function and long-term prognosis in patients with heart failure 55
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry 55
A 'clover' coronary artery: role of coronary computed tomography to indicate optimal treatment in aneurysmal coronary artery disease 54
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 54
Safety and efficacy of doxazosin as an "add-on" antihypertensive therapy in mild to moderate heart failure patients 53
Safety and Efficacy of Polymer-Free Drug-Eluting Stents 52
Percutaneous Repair for Secondary Mitral Regurgitation 52
Prognostic Value of Pre-operative Atrial Fibrillation in Patients with Secondary Mitral Regurgitation Undergoing MitraClip Implantation 52
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 52
[Metabolic therapy for heart failure]. FT Terapia metabolica per l'insufficienza cardiaca 51
Valsartan for prevention of recurrent atrial fibrillation (New England Journal of Medicine (2009) 360, (1606-1617)) 51
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 51
Inappropriate dose of nonvitamin-K antagonist oral anticoagulants: prevalence and impact on clinical outcome in patients with nonvalvular atrial fibrillation 51
Right ventricular endomyocardial biopsy in patients with cardiac magnetic resonance showing left ventricular myocarditis 51
[Cardiac involvement by non-Hodgkin's lymphoma in an HIV-positive patient with hypertrophic obstructive cardiomyopathy]. FT Localizzazione cardiaca di linfoma non-Hodgkin in soggetto HIV positivo affetto da cardiomiopatia ipertrofica ostruttiva. 50
Echocardiographic classification of chronic ischemic mitral regurgitation caused by restricted motion according to tethering pattern 50
F. Caviezel, G.B. Picotti, A. Margonato, G. Slaviero, M.D. Galva, P. Camagna, G.P. Bondiolotti, M.O. Carruba, G. Pozza: Plasma adrenaline and noradrenaline concentrations in diabetic patients with and without autonomic neuropathy at rest and during sympathethic stimulation. Diabetologia. 1982 50
A high carbohydrate meal yields a lower ischemic threshold than a high fat meal in patients with stable coronary disease 50
Pulsed tissue Doppler imaging detects early myocardial dysfunction in asymptomatic patients with severe mitral regurgitation 50
A Complicated Case of Resistant Hypertension 49
Transcatheter Edge-To-Edge Repair in COAPT-ineligible Patients: Incidence and Predictors of 2-year Good Outcome 49
Comparison of enoximone echocardiography, positron emission tomography and dobutamine echocardiography for prediction of recovery of myocardial dysfunction after revascularization 49
Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion 49
Validation of heart and lung teleauscultation on an Internet-based system 48
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 47
Tricuspid valve imaging 47
New pharmacological targets in the treatment of heart failure: Inhibition of free fatty oxidation by trimetazidine 47
Direct oral anticoagulants versus percutaneous left atrial appendage occlusion in atrial fibrillation: 5-year outcomes 46
Myocardial viability assessed with fluorodeoxyglucose and PET in patients with Q wave myocardial infarction receiving thrombolysis: Relationship to coronary anatomy and ventricular function 46
Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease 46
Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure 46
Potential Cardiologic Protective Effects of Acetylcholinesterase Inhibitors in Patients With Mild to Moderate Dementia 45
Echocardiographic features of post-transcatheter aortic valve implantation thrombosis and endocarditis 45
Genetic and metabolic risk factors for the development of complications of type 2 diabetes mellitus 45
Functional testing as the most accurate tool for risk stratification in patients with micro-and macrovessel coronary artery disease 44
Percutaneous left atrial appendage closure versus nonvitamin K oral anticoagulants in patients with non-valvular atrial fibrillation and high bleeding risk 44
Primary Cardiac Lymphoma in an Immunocompetent 71-Year-Old Man 43
Young Patient with Advanced Heart Failure No Longer a Candidate for Heart Transplantation after MitraClip® Procedure 43
Loss of Leaflet Insertion After Percutaneous Mitral Valve Repair Requiring Left Ventricular Assist Device Implantation: Usefulness of 3D Multiplanar Reconstruction 43
Genetic and metabolic risk factors for the development of late complications in type 1 (insulin dependent) diabetes 43
Prevalence, Burden and Echocardiographic Features of Moderate to Severe Tricuspid Regurgitation: Insights from a Tertiary Referral Center (vol 3, pg 123, 2019) 43
Meta-Analysis of Relation Between Left Ventricular Dysfunction and Outcomes After Transcatheter Mitral Edge-to-Edge Repair 42
Early detection by the Tei index of carvedilol-induced improved left ventricular function in patients with heart failure 42
Identification of High-Risk Patients after ST-Segment-Elevation Myocardial Infarction 41
Intra-procedural monitoring protocol using routine transthoracic echocardiography with backup trans-oesophageal probe in transcatheter aortic valve replacement: a single centre experience 41
Lung ultrasound-guided therapy reduces acute decompensation events in chronic heart failure 41
Risk factors for micro- and macroangiopathic complications in type 2 diabetes: lack of association with acetylator phenotype, chlorpropamide alcohol flush and ABO and Rh blood groups 41
Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation 41
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy 41
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry 41
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 41
Doppler tissue imaging: A reliable method for estimation of left ventricular filling pressure in patients with mitral regurgitation 40
Jugular approach for percutaneous closure of atrial septal defect 40
P1246Age-, body size-, and sex-specific reference values for tricuspid valve apparatus parameters by real-time three-dimensional transthoracic echocardiography 40
Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study 40
Usefulness of Transcatheter Patent Foramen Ovale Closure in Migraineurs With Moderate to Large Right-to-Left Shunt and Instrumental Evidence of Cerebrovascular Damage 39
Safety and efficacy of first-generation and second-generation drug-eluting stents in the setting of acute coronary syndromes 39
Assessment of stress-induced pulmonary interstitial edema by chest ultrasound during exercise echocardiography and its correlation with left ventricular function 39
Quantitative radionuclide angiocardiography using gold 195m 39
Impact and evolution of right ventricular dysfunction after successful MitraClip implantation in patients with functional mitral regurgitation 39
Impaired vascular reactivity in patients with erectile dysfunction [2] (multiple letters) 39
Beneficial Electrophysiological Effects of Trimetazidine in Patients With Postischemic Chronic Heart Failure 38
The anti-ischemic effect of trimetaxidine in patients with postprandial myocardial ischemia is unrelated to meal composition 38
Totale 5.880
Categoria #
all - tutte 111.075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.075


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202139 0 0 0 0 0 27 9 2 0 0 1 0
2021/2022181 4 1 7 79 10 15 10 7 17 4 6 21
2022/20231.611 664 327 105 17 9 180 89 104 41 34 25 16
2023/2024638 22 31 76 53 57 121 47 52 6 23 34 116
2024/20253.859 511 60 33 81 91 327 429 357 731 530 313 396
2025/20265.866 870 1.200 1.051 1.793 756 196 0 0 0 0 0 0
Totale 12.387